白足蚜小蜂对桃蚜的取食和寄生功能反应及搜寻效应

为评估白足蚜小蜂Aphelinus albipodus对桃蚜Myzus persicae的防控效果,在室内测定了白足蚜小蜂对不同发育阶段桃蚜的功能反应和搜寻效应,并对种内干扰和分摊竞争强度进行了比较。结果表明:白足蚜小蜂对不同发育阶段桃蚜的取食量和寄生量均随着蚜虫密度增加而增加,取食量和寄生功能反应均符合HollingⅡ模型。白足蚜小蜂对桃蚜的理论最大取食量2.809头,瞬时攻击率0.218,处理时间0.023 d;白足蚜小蜂对3～4日龄桃蚜寄生量最大,为47.62头,寄生瞬时攻击率0.723,处理时间0.021 d。搜寻效应均随蚜虫密度的增加而下降,且与蚜虫密度呈负相关。白足蚜小蜂个体之间存在种内干扰作用,随着自身密度增加,单头寄生率相对下降,分摊竞争强度增大,干扰效应符合Hassell-varley模型。由功能反应、种内干扰等指标可见白足蚜小蜂对桃蚜具有较好的防控作用。     

羊免疫布鲁菌病疫苗(S2株)免疫抗体长期监测结果的试验

为探究羊经布鲁菌病疫苗(S2株)免疫后的血清抗体长期动态消长规律,本试验于2012年9月-2015年9月选取阿拉善盟阿拉善左旗96只山羊、100只绵羊作为试验动物,经布鲁菌疫苗(S2株)100亿CFU、200亿CFU不同免疫剂量灌服,分别于免疫前和免疫后不同时间段采血分离血清,应用虎红平板凝集试验和试管凝集试验进行抗体监测。结果表明,绵羊组在一免后20d时,血清抗体阳性率达到最高峰,之后呈下降趋势,150d抗体阳性率降至0%,免疫后180d^360d,绵羊组抗体阳性率一直处于较低水平(0%~4%),二免和三免后不同时间段免疫抗体消长规律与首次免疫基本一致;山羊组抗体阳性率在免疫后20 d时,血清抗体阳性率达到最高峰,之后呈下降趋势,免疫后90 d^360 d,免疫抗体时高时低,起伏较大,无明显规律,二免和三免后不同时间段免疫抗体消长规律与首次免疫基本一致,结果同时表明,100亿CFU和200亿CFU两个免疫剂量组的抗体阳性率无明显差异。     

GC-MS分析慢性氨气应激对肉鸡血清代谢物的影响

【目的】随着养殖业集约化和规模化的发展,舍内环境对畜禽生长的影响日益突出。在密闭舍饲条件下,不断产生有毒有害气体,其中氨气的危害最大,降低畜禽生产性能,威胁动物健康。为此开展慢性氨气应激对肉鸡血清代谢物影响的研究,从小分子物质和代谢途径方面探究氨气导致机体代谢发生的变化,为舍内氨气的合理调控提供数据支持。【方法】试验采用单因素完全随机设计,将96只21日龄健康AA肉鸡随机分成对照组和试验组,每组设4个重复,每个重复12只鸡。对照组氨气浓度为0 mg·kg^-1,试验组氨气浓度为45 mg·kg^-1。试验在人工模拟呼吸舱内进行,呼吸舱采用全自动化控制温湿度等养殖条件,采用网上平养,自由采食和饮水,24h光照,试验期为21d。在肉鸡42日龄时,从每个重复中随机抽取2只,翅静脉采血,分离血清。将血清样品预处理后,采用气相色谱/质谱联用技术(gas chromatograph tandem mass spectrometer technology, GC-MS)检测代谢产物,利用质谱数据库对其进行鉴定。通过主成分分析、偏最小二乘法判别分析、正交偏最小二...     

陕北毛乌素沙地仁用杏丰产栽培技术体系

针对陕北毛乌素沙地地势较为平埋，光热资源丰富，水资源相对充足，但干旱少雨，降水集中，蒸发量大，风沙危害频繁，土质疏松、漏肥、漏水现象严重等特殊的自然条件，提出了适宜该地区采用的仁用杏丰产栽培技术体系。     

Comparison of the pharmacokinetics and thermal antinociceptive pharmacodynamics of 20 µg kg−1 buprenorphine administered sublingually or intravenously in cats

Little is known about the analgesic action of buprenorphine (BUP) in cats. Relative to man, the cat has a more alkaline oral pH, which may make this an effective route for administering BUP in this species. This study aimed to assess and compare the pharmacokinetics and pharmacodynamics of sublingual (S‐L) and IV administration of BUP. Thermal threshold (TT) was measured and blood samples were collected following IV or S‐L administration (20 µg kg^?1) of the injectable formulation. Six cats (five spayed females, one castrated male, 4.1–6.6 kg) were used. Each cat received both treatments in a randomized cross‐over study design with 1 month between experiments. Twenty‐four hours prior to each study, the lateral thorax of each of the cats was shaved, cephalic and jugular catheters placed, and oral pH measured. On the day of the study, TT was measured using a ‘thorax‐mounted’ thermal threshold‐testing device specifically developed for cats. The cats were free to move around. Skin temperature was recorded before each test, then the heater activated. When the cat responded by flinching, turning, or jumping, the stimulus was terminated and the threshold temperature was recorded. The thermal threshold cut‐off point was 55.5 °C. Three baseline thresholds were recorded before treatment with S‐L or IV (via cephalic catheter) BUP (20 µg kg^?1). Blood was withdrawn (jugular) at 1, 2, 4, 6, 10, 15, 30, 45, 60 minutes and at 2, 4, 6, 8, 12, and 24 hours post‐administration. TT was measured every 30 minutes?6 hours, 1–12 hours, and at 24 hours post‐administration. Plasma was immediately separated, stored at ?20.5 °C, and assayed within 4 months using a commercially available ¹²⁵I radioimmunoassay. Threshold data were analyzed using anova with a repeat factor of time. No adverse effects were noted. Pupils were dilated for up to 9 hours post‐BUP. Behavioral changes were calm euphoria. Measured oral pH was 9 in each cat. Pre‐treatment mean threshold (±SD) was 41.2 ± 0.9 °C in the S‐L group and 40.8 ± 0.85 °C in the IV group. There were no significant differences between the groups with respect to thresholds over time (p = 0.72). Thresholds were significantly increased from 30 to 360 minutes in both the groups (>44.615 °C). Peak plasma BUP (C_max) was lower (11 ± 6.7 ng mL^?1vs. 92.9 ± 107.9 ng mL^?1) and occurred later (T_max) (30 minutes vs. 1 minute) after S‐L compared to IV administration, respectively. BUP (20 µg kg^?1)‐administered S‐L or IV provided antinociception between 30 and 360 minutes after administration. Plasma levels did not correspond to TT.